Impact of CYP2C19 genotype on escitalopram exposure and establishment of a dose algorithm for genotype-based individualization of escitalopram therapy

被引：0
|
作者：
Jukic, M. [1 ]
Molden, E. [2 ]
Ingelman-Sundberg, M. [1 ]
机构：
[1] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden
[2] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2017年 / 27卷
关键词：
D O I：
10.1016/S0924-977X(17)31537-7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.f.017
引用
收藏
页码：S856 / S856
页数：1
相关论文
共 50 条
  • [31] CYP2C19 Genotype and Cardiovascular Events Reply
    Nissen, Steven E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (14): : 1485 - 1485
  • [32] CYP2C19 Genotype and Outcomes of Clopidogrel Treatment
    Siasos, Gerasimos
    Tousoulis, Dimitris
    Stefanadis, Christodoulos
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 481 - 482
  • [33] CYP2C19 polymorphisms and outcomes of Escitalopram treatment in Brazilians with major depression
    de Brito, Rodrigo Bernini
    Ghedini, Paulo Cesar
    HELIYON, 2020, 6 (05)
  • [34] CYP2C19 METABOLIZER STATUS PREDICTS ESCITALOPRAM PHARMACOKINETICS IN CHILDREN AND ADOLESCENTS
    Vaughn, Sam
    Poweleit, Ethan
    Desta, Zeruesenay
    Strawn, Jeffrey
    Ramsey, Laura
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S215 - S215
  • [35] CYP2C19 INFLUENCE ON ESCITALOPRAM EFFICACY AND TOLERABILITY IN YOUTH WITH ANXIETY AND DEPRESSION
    Ramsey, Laura B.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S301 - S301
  • [36] CYP2C19 genotype and the PPIs - focus on rabeprazole
    Lim, PWY
    Goh, KL
    Wong, BCY
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 : S22 - S28
  • [37] Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically-Based Pharmacokinetic Modeling and Clinical Observation
    Jang, Yoo Jin
    Kim, Doh Kwan
    Lim, Shinn-Won
    Hong, Eunjin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (03) : 826 - 835
  • [38] Impact of CYP2C19 genotype in ischaemic stroke patients treated with clopidogrel
    Doney, A.
    Palmer, C.
    Morant, S.
    Flynn, R.
    MacDonald, T.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 29 - 29
  • [39] Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention
    Lee, Seung Hun
    Jeong, Young-Hoon
    Hong, David
    Choi, Ki Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Hahn, Joo-Yong
    Choi, Seung-Hyuck
    Gwon, Hyeon-Cheol
    Jeong, Myung Ho
    Kim, Byeong-Keuk
    Joo, Hyung Joon
    Chang, Kiyuk
    Park, Yongwhi
    Ahn, Sung Gyun
    Suh, Jung-Won
    Lee, Sang Yeub
    Cho, Jung Rae
    Her, Ae-Young
    Kim, Hyo-Soo
    Kim, Moo Hyun
    Lim, Do-Sun
    Shin, Eun-Seok
    Song, Young Bin
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (07) : 829 - 843
  • [40] Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects
    Rosenborg, Staffan Ohlsson
    Mwinyi, Jessica
    Andersson, Maria
    Baldwin, R. Michael
    Pedersen, Rasmus Steen
    Sim, Sarah C.
    Bertilsson, Leif
    Ingelman-Sundberg, Magnus
    Eliasson, Erik
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (12) : 1175 - 1179
12345